Lori Anne Kunkel's Net Worth

$9.72 Million

Estimate Recalculated Nov 5, 2024 02:08PM EST

Who is Lori Anne Kunkel?

Lori Anne Kunkel has an estimated net worth of $9.72 Million. This is based on reported shares across multiple companies, which include Nurix Therapeutics, Inc., Loxo Oncology, Inc., CURIS INC, Tocagen Inc, Oric Pharmaceuticals, Inc., PHARMACYCLICS INC, and Enliven Therapeutics, Inc..

SEC CIK

Lori Anne Kunkel's CIK is 0001536368

Past Insider Trading and Trends

2018 was Lori Anne Kunkel's most active year for acquiring shares with 7 total transactions. Lori Anne Kunkel's most active month to acquire stocks was the month of May. 2018 was Lori Anne Kunkel's most active year for disposing of shares, totalling 15 transactions. Lori Anne Kunkel's most active month to dispose stocks was the month of May. 2018 saw Lori Anne Kunkel paying a total of $229,948.16 for 251,142 shares, this is the most they've acquired in one year. In 2019 Lori Anne Kunkel cashed out on 119,392 shares for a total of $24,594,701.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nurix Therapeutics, Inc. (NRIX) Snapshot price: $23.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-54.03K
—
—
0
Jul 17
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
May 6
Form 3
—
0
—
—
0
No matching records found

Loxo Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
$87.01
-$833,589.10
0
Scheduled
Oct 1
Form 4
-100.00%
-6.84K
$93.19
-$6,843,545.53
0
Scheduled
Jun 14 - Jun 15
Form 4
—
0
—
—
0
Jun 13
Form 4
-42.23%
-5.00K
$132.68
-$663,378.28
6.84K
Scheduled
Apr 20
Form 4
-29.69%
-5.00K
$84.91
-$424,570.44
11.84K
Scheduled
Nov 2
Form 4
-37.26%
-10.00K
$75.17
-$751,731.00
16.84K
Scheduled
Aug 22
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jul 28
Form 3
—
0
—
—
0
No matching records found

CURIS INC (CRIS) Snapshot price: $4.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Mar 2
Form 4
-40.00%
-14.80K
$1.05
-$15,581.44
22.2K
Scheduled
Jan 23
Form 4
—
0
—
—
0
Jan 21
Form 4
∞
185K
—
—
185K
Jan 22
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Nov 11
Form 3
—
0
—
—
0
No matching records found

Tocagen Inc (FBRX) Snapshot price: $7.85

Acting-Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 4
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
Jan 11
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Apr 12
Form 3
—
0
—
—
0
No matching records found

Oric Pharmaceuticals, Inc. (ORIC) Snapshot price: $9.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
∞
20.5K
$3.75
$76,875.00
20.5K
Jun 3
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
No matching records found